Related Experiment Video
Updated: Jun 8, 2026

A Multi-Modal Approach to Assessing Recovery in Youth Athletes Following Concussion
Published on: September 25, 2014
Persistent neurological sequelae in children and adolescents after SARS-CoV-2: a scoping review
Salma Zouari Mallouli1,2, Daniel Munblit3,4, Ekaterina Iakovleva4
1Child Neurology Department at Hedi Chaker, Sfax University Hospital, Sfax, Tunisia. mallouli.salma26@gmail.com.
Insights
Persistent neurological symptoms, including pain and sleep issues, are a significant concern for children and adolescents after COVID-19 infection. This review highlights the substantial burden of long COVID-19 in this age group.
Area of Science:
- Neurology
- Pediatrics
- Infectious Diseases
Background:
- COVID-19 pandemic has led to significant health planning and research focus.
- Long-term consequences of acute disease, containment measures, and ongoing symptoms pose a global challenge.
- Understanding effects on children and adolescents is crucial for tailored health directives.
Purpose of the Study:
- To review the spectrum of persistent neurological sequelae in children and adolescents post-SARS-CoV-2 infection.
- To inform future health policies regarding pediatric long COVID-19.
- To synthesize global data on neurological manifestations in young populations.
Main Methods:
- Scoping review conducted following PRISMA-ScR guidelines.
- Literature search across major databases (PubMed, Google Scholar, Web of Science, Cochrane, WHO COVID).
- Included peer-reviewed articles on pediatric long COVID-19 neurological symptoms from September 2020 to September 2024.
Main Results:
- Pain and sensory problems were the most prevalent neurological sequelae (81.5%).
- Sleep disturbances (15.9%) and cognitive difficulties (2.4%) were also reported.
- Neurological symptoms were more common in the 11-16 age group, with immunocompetent children at higher risk.
Conclusions:
- A considerable burden of persistent neurological symptoms exists in children and adolescents following COVID-19.
- These findings necessitate consideration in healthcare decision-making for pediatric populations.
- Further research and targeted interventions are warranted for pediatric long COVID-19.
Objectives:
For the past five years, COVID-19 has not only been a priority for health planning but also a hotspot for clinical research. Yet, the weight of the worldwide COVID-19 pandemic arises from the critical phase consequences due to the onset of acute disease, associated containment measures, and documented ongoing disabling symptoms. Investigating the global longitudinal effects on children and adolescents will inform future health directives tailored to this population's needs. This review aimed to report the spectrum of persistent neurological sequelae in children and adolescents following SARS-CoV-2 infection.
Methods:
Hence, we conducted a scoping review following the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). We included the peer-reviewed articles from PubMed, Google Scholar, Web of Science, Cochrane Library, and WHO COVID database to identify relevant literature on long-COVID-19 neurological signs/symptoms among children and adolescents. The search covered the period between September 2020 and September 2024.
Results:
The results of our analysis of 33 studies found long-COVID-19-related neurological signs/symptoms were predominantly: pain and sensory problems (N = 74,612/91,543; 81.5%), followed by sleep disturbances (N = 14,630/91,543; 15.9%), and cognitive difficulties (N = 2274/91,543; 2.4%). The global prevalence of long COVID-19 neurological signs/symptoms was estimated between 0.4% (20/5032; 95% CI = 2.1-3%) and 34% (27/79) based on data obtained through online questionnaire; while it varied between 1.8% (4/215) and 83.14% (74/89; 95%CI = - 0.12; 0.30) based on patient assessment. Long-COVID-19-related neurological signs/symptoms were more common in the 11-16 age group. Children with immunocompetent profiles were at higher risk of developing long-COVID-19-related neurological signs/symptoms.
Conclusion:
Our results demonstrate a considerable burden of COVID-19-related persistent neurological signs/symptoms in children and adolescents, which should be taken into consideration in healthcare decision-making.
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction
Secondary Spinal Cord Injury llI: Pathophysiology

